Meghan McGarry, MD, MS

TitleAssistant Professor
SchoolUCSF School of Medicine
Address550 16th. Street
San Francisco CA 94158
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Whitworth CollegeBS Biology2005
    University of WashingtonM.D. 2009
    Rainbow Babies and Children's HospitalPediatric Residency2012
    University of California San FranciscoPediatric Pulmonology2015
    University of California San FranciscoMasters Clinical Research2015
    Collapse Awards and Honors
    NHLBI2018  - 2023K23 Career Development Award
    Cystic Fibrosis Foundation2016  - 2019Harry Schwachman Cystic Fibrosis Clinical Scholar
    UCSF2017Jane Addams Social Justice Award
    American Thoracic Society2016ATS International Conference Pediatric Abstract Scholarship
    NICHD/NIGMS2013  - 2016Pediatric Clinical Pharmacology, Drug Action, and Pharmacogenetics T32
    California Thoracic Society2015Best Research, Fellows Poster Presentation
    Breathe California2015Walter Travel Grant
    American Thoracic Society2014ATS International Conference Pediatric Abstract Scholarship
    California CF Consortium2014Fellow’s Scholarship
    California CF Consortium2013Fellow’s Scholarship
    Rainbow Babies and Children’s Hospital2010Resident Teacher of the Year

    Collapse Overview 
    Collapse Overview
    Dr. McGarry is a Pediatric Pulmonologist who researches cystic fibrosis. Her main focus is researching health disparities in cystic fibrosis, particularly in minorities. She is conducting a cohort study of lung function in Latinos/Hispanics with cystic fibrosis. She also does research in diversity in clinical trials in cystic fibrosis.

    Dr. McGarry studied Biology at Whitworth College. She then attended University of Washington School of Medicine, working in many underserved regions from Alaska to Zambia. She completed her Pediatric residency at Rainbow Babies and Children's Hospital. She completed her Pediatric Pulmonary and Pediatric Clinical Pharmacology Fellowships at University of California San Francisco. She also completed her Masters in Clinical Research at University of California San Francisco.

    Collapse Research 
    Collapse Research Activities and Funding
    Risk Factors For Worse Lung Function In Latinos With Cystic Fibrosis
    NIH/NHLBI K23HL133437Feb 1, 2018 - Jan 31, 2023
    Role: Principal Investigator
    Risk Factors For Worse Lung Function In Latinos With Cystic Fibrosis
    Cystic Fibrosis Foundation Jul 1, 2016 - Jun 30, 2019
    Role: Primary Investigator
    Ivacaftor in non-G551D cystic fibrosis patients
    Cystic Fibrosis Foundation, Research Development Program Grant May 1, 2013 - Apr 30, 2015
    Role: Co-Investigator
    Clinical Pharmacology, Drug Action and Pharmacogenetics
    NIH/NIGMS T32GM007546Jul 1, 1977 - Jun 30, 2020
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. McGarry M, Neuhaus JM, Nielson DW, Burchard E, Ly NP. Pulmonary function disparities exist and persist in Hispanic patients with cystic fibrosis: A longitudinal analysis. Pediatr Pulmonol. 2017 Oct 30. PMID: 29082671.
      View in: PubMed
    2. McGarry M, Illek B, Ly NP, Zlock L, Olshansky S, Moreno C, Finkbeiner WE, Nielson DW. In vivo and in vitro ivacaftor response in cystic fibrosis patients with residual CFTR function: N-of-1 studies. Pediatr Pulmonol. 2017 Apr; 52(4):472-479. PMID: 28068001.
      View in: PubMed
    3. Oh S, Du R, Zeiger AM, Mcgarry ME, Hu D, Thakur N, Pino-Yanes M, Galanter JM, Farber HJ, Eng C, Nishimura KK, Huntsman S, Meade K, Avila P, Serebrisky D, Bibbins-Domingo K, Lenoir MA, Ford JG, Brigino-Buenaventura E, Rodriguez-Cintron W, Thyne SM, Sen S, Rodriguez-Santana JR, Williams K, Kumar R, Burchard EG. Breastfeeding associated with higher lung function in African American youths with asthma. J Asthma. 2016 Dec 08; 1-10. PMID: 27929698.
      View in: PubMed
    4. McGarry M, McColley SA, et al. Minorities Are Underrepresented in Clinical Trials of Pharmaceutical Agents for Cystic Fibrosis. Ann Am Thorac Soc. 2016 Oct; 13(10):1721-1725. PMID: 27410177.
      View in: PubMed
    5. McGarry M, Castellanos E, Thakur N, Oh SS, Eng C, Davis A, Meade K, LeNoir MA, Avila PC, Farber HJ, Serebrisky D, Brigino-Buenaventura E, Rodriguez-Cintron W, Kumar R, Bibbins-Domingo K, Thyne SM, Sen S, Rodriguez-Santana JR, Borrell LN, Burchard EG. Obesity and bronchodilator response in black and Hispanic children and adolescents with asthma. Chest. 2015 Jun; 147(6):1591-1598. PMID: 25742612; PMCID: PMC4451713.
    6. Thakur N, McGarry M, S Oh S, M Galanter J, Finn PW, Burchard EG. The lung corps' approach to reducing health disparities in respiratory disease. Ann Am Thorac Soc. 2014 May; 11(4):655-60. PMID: 24697756; PMCID: PMC4225795.
    7. McGarry M, Nielson DW. Normalization of sweat chloride concentration and clinical improvement with ivacaftor in a patient with cystic fibrosis with mutation S549N. Chest. 2013 Oct; 144(4):e1-e4. PMID: 24081349; PMCID: PMC4502741.
    Meghan's Networks
    Derived automatically from this person's publications.
    People in Profiles who have published with this person.
    Related Authors
    People who share related concepts with this person.
    Back to TOP